Digital Digital therapeutics at a turning point: What we heard at DT... This year the digital therapeutics space took a hit with the downfall of Pear Therapeutics,
Views & Analysis Frontiers Health Steering Committee spotlight: Eugene Borukh... With Frontiers Health 2022 mere weeks away, we continue to interview members of the steering committee, gaining insight into what to expect from Milan.
Views & Analysis 7 questions: Bayer's Eugene Borukhovich Eugene Borukhovich's perspective on digital health and its future.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
